Fractalkine in Health and Disease.

Area of Science:

• Immunology
• Molecular Biology
• Oncology

Background:

• Chemokines are crucial signaling proteins involved in immune responses.
• Fractalkine (CX3CL1) is a unique chemokine with both membrane-bound and soluble forms, distinct from other chemokines.
• The fractalkine/CX3CR1 signaling pathway is implicated in nervous system functions and leukocyte migration.

Purpose of the Study:

• To review the known biology of fractalkine (CX3CL1).
• To explore the controversial roles of fractalkine in cancer progression and anti-tumor immunity.
• To discuss fractalkine's actions via its receptor and integrin activation.

Main Methods:

• Literature review of existing studies on fractalkine (CX3CL1).
• Analysis of fractalkine's signaling mechanisms, including CX3CR1 interaction and integrin activation.
• Synthesis of evidence regarding fractalkine's dual role in cancer.

Main Results:

• Fractalkine exhibits diverse biological functions depending on its form (membrane-bound vs. soluble).
• The fractalkine/CX3CR1 axis has established roles in the nervous system and inflammation.
• Fractalkine's involvement in cancer is complex, with evidence supporting both anti-cancer and pro-carcinogenic activities.

Conclusions:

• Fractalkine (CX3CL1) possesses multifaceted roles beyond immune cell trafficking.
• Understanding fractalkine's dual function in cancer is critical for developing targeted therapies.
• Further research is needed to elucidate the precise mechanisms governing fractalkine's impact on anti-tumor immunity and cancer progression.